Skip to main content
E

ELFA MEDICAMENTOS S.A. — Investor Relations & Filings

LEI · 5493005QD7AE0Y035Y20 SA Wholesale and retail trade
Open in API
Filings indexed 60 across all filing types
Latest filing 2026-04-27 Share Issue/Capital Cha…
Country BR Brazil
Listing SA

About ELFA MEDICAMENTOS S.A.

Elfa Medicamentos S.A. is a specialized distributor of pharmaceutical products and medical-hospital supplies serving the comprehensive healthcare value chain. The company facilitates the wholesale and retail trade of prescription medications, dermatological products, and proprietary drugs. Its operational scope extends to the provision of hospital disposable materials, orthotics, prosthetics, and special materials (OPME). Beyond product distribution, the company offers integrated healthcare logistics solutions designed to optimize supply chain efficiency for hospitals and clinics. Controlled by Patria Investimentos, Elfa Medicamentos S.A. has expanded its market presence through strategic acquisitions, consolidating its role as a key intermediary between manufacturers and healthcare providers. Its service model emphasizes the reliable delivery of critical medical supplies and specialized materials to diverse healthcare segments.

Recent filings

Filing Released Lang Actions
Aumento de Capital
Share Issue/Capital Change Classification · 1% confidence The document is a “Fato Relevante e Aviso aos Acionistas” announcing and detailing a capital increase (“Aumento de Capital”) with the issuance of new preferred shares, subscription rights for existing shareholders, terms & conditions, and related annexes. It is not an annual or interim report, earnings release, board change, or proxy solicitation. It is a specific announcement of a new share issue and capital structure change. Therefore, it best fits the Share Issue/Capital Change category.
2026-04-27 Portuguese
AGO - (i) as demonstrações financeiras, com as respectivas notas explicativas, acompanhadas do parecer dos auditores independentes e do parecer do Comitê de Auditoria não estatutário; AGO - (ii) as co
Regulatory Filings Classification · 1% confidence The document is the full minutes (“Ata”) of an Ordinary and Extraordinary General Shareholders’ Meeting including convocation details, agenda items, deliberations, vote approvals, board elections, capital increase approval, and related corporate governance resolutions. It is not a pre-meeting proxy statement, not an earnings release, nor a standalone audit or annual report. There is no specific category for meeting minutes, so under the guidelines it falls into the “General Regulatory Filings” fallback category.
2026-04-27 Portuguese
DFP 2025
Regulatory Filings
2026-03-17 Portuguese
ITR 2025-Q3
Regulatory Filings
2025-11-13 Portuguese
ITR 2025-Q3 v2
Regulatory Filings
2025-11-13 Portuguese
ITR 2025-Q2
Regulatory Filings
2025-08-13 Portuguese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.